CVE-2014-0967

Cross-site scripting (XSS) vulnerability in the GDS component in IBM InfoSphere Master Data Management - Collaborative Edition 10.x and 11.x before 11.0 FP4 and InfoSphere Master Data Management Server for Product Information Management 9.0 and 9.1 allows remote authenticated users to inject arbitrary web script or HTML via a crafted URL.

View on NVD

Severity

N/A

EPSS

Probability of exploitation (next 30 days): 0.0017 (0.2%)

Percentile: 37.2%

EPSS: 2026-05-06

Affects

ibm:infosphere_master_data_management_collaboration_serveribm:infosphere_master_data_management_server_for_product_information_management

Technical description

Published: 7/19/2014, 5:09:27 AM

Last modified: 5/6/2026, 10:30:45 PM

References

How to read this card

Actively exploited

KEV (Known Exploited Vulnerabilities) is CISA's catalog of CVEs confirmed as actively exploited in the real world. If a CVE is on KEV, someone is already using it in attacks.

CVSS 10.0

CVSS 10.0 — máxima severidad teórica. Explotable de forma remota, sin privilegios, con impacto total. Aún no confirmada como explotada en el mundo real, pero parchea ya.

AI-recommended

Un modelo de lenguaje revisó el CVE y consideró que afecta a software ampliamente desplegado o herramientas comunes de desarrollo. Un humano del equipo aprobó la publicación antes de que llegara aquí.

Categorías de impacto que evalúa la IA

widely_deployed_infra — kernel Linux, OpenSSL, glibc, k8s, Docker, nginx, OpenSSH.

popular_dev_tooling — Node.js, Python, Go, React, Next.js, librerías comunes de npm/pip.

common_consumer_software — Chrome, Firefox, Windows, macOS, apps móviles populares.

enterprise_saas — GitHub, GitLab, Atlassian, Salesforce, Cisco, Fortinet, Ivanti.

niche_software — CMS regionales, herramientas de hobby, librerías de poco uso.

not_relevant — firmware específico de proveedor, software descontinuado.

EPSS — EPSS (Exploit Prediction Scoring System) by FIRST.org estimates the probability that a CVE will be exploited in the next 30 days. Range is 0 to 1; very fresh CVEs typically score low until evidence accumulates.